GlaxoSmithKline plc (GSK) Given a GBX 1,850 Price Target by Berenberg Bank Analysts

Berenberg Bank set a GBX 1,850 ($23.88) price target on GlaxoSmithKline plc (LON:GSK) in a research report released on Friday, May 5th. The firm currently has a neutral rating on the stock.

GSK has been the topic of several other reports. BNP Paribas reaffirmed an underperform rating and set a GBX 1,520 ($19.62) target price on shares of GlaxoSmithKline plc in a report on Sunday, January 15th. Shore Capital reaffirmed a hold rating on shares of GlaxoSmithKline plc in a report on Friday, January 6th. Jefferies Group LLC raised their target price on GlaxoSmithKline plc from GBX 1,780 ($22.98) to GBX 1,800 ($23.23) and gave the stock a buy rating in a report on Friday, February 17th. Beaufort Securities reaffirmed a buy rating and set a GBX 1,750 ($22.59) target price on shares of GlaxoSmithKline plc in a report on Thursday, February 16th. Finally, Goldman Sachs Group Inc raised their target price on GlaxoSmithKline plc from GBX 1,800 ($23.23) to GBX 1,850 ($23.88) and gave the stock a buy rating in a report on Tuesday, January 24th. Three investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and eight have issued a buy rating to the company. GlaxoSmithKline plc has a consensus rating of Hold and a consensus target price of GBX 1,743.36 ($22.50).

ILLEGAL ACTIVITY NOTICE: This report was originally reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this report on another site, it was stolen and republished in violation of United States & international copyright & trademark law. The original version of this report can be viewed at https://www.chaffeybreeze.com/2017/05/20/berenberg-bank-analysts-give-glaxosmithkline-plc-gsk-a-gbx-1850-price-target-updated.html.

The business also recently announced a dividend, which will be paid on Thursday, July 13th. Investors of record on Thursday, May 11th will be paid a dividend of GBX 19 ($0.25) per share. The ex-dividend date of this dividend is Thursday, May 11th. This represents a yield of 1.21%.

In related news, insider Moncef Slaoui bought 56 shares of the stock in a transaction that occurred on Tuesday, March 7th. The stock was purchased at an average cost of GBX 2,072 ($26.75) per share, with a total value of £1,160.32 ($1,497.77). Also, insider Vivienne Cox bought 335 shares of the stock in a transaction that occurred on Wednesday, April 26th. The shares were bought at an average cost of GBX 1,583 ($20.43) per share, with a total value of £5,303.05 ($6,845.29). Insiders have purchased a total of 718 shares of company stock valued at $1,183,024 over the last three months.

About GlaxoSmithKline plc

GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases.

12 Month Chart for LON:GSK

Receive News & Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply